SCHEMBL10195189

SCHEMBL10195189

CCc1ccc(Oc2ncc(Cl)cc2Cl)cc1C1=C(O)CC(C)(C)CC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.43
LMNA P02545 2/20 0.43
TSHR P16473 2/20 0.43
CYP2C9 P11712 1/20 0.43
APEX1 P27695 1/20 0.43
LIPE Q05469 4/20 0.41
BCHE P06276 1/20 0.41
DRD1 P21728 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
SCN9A Q15858 2/20 0.36
ALDH1A1 P00352 4/20 0.36
HTT P42858 1/20 0.36
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35
IP6K1 Q92551 1/20 0.35
IP6K3 Q96PC2 1/20 0.35
IP6K2 Q9UHH9 1/20 0.35
PPARG P37231 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16180989 0.91 DRD1 (0.42) MAPK1SMN1; SMN2LMNATSHRLIPE
SCHEMBL10195190 0.91 PPARG (0.36) MAPK1SMN1; SMN2LMNATSHRDRD1
SCHEMBL10195191 0.88 RAB9A (0.47) SMN1; SMN2LMNALIPEALDH1A1HTT
SCHEMBL10195494 0.87 SMN1; SMN2 (0.38) SMN1; SMN2LMNATSHRCYP2C9ALDH1A1
SCHEMBL10196204 0.86 MAPK1 (0.48) MAPK1SMN1; SMN2LMNATSHRCYP2C9
SCHEMBL10195476 0.86 LIPE (0.42) MAPK1SMN1; SMN2LMNATSHRCYP2C9
SCHEMBL10195510 0.85 SMN1; SMN2 (0.37) SMN1; SMN2LMNATSHRLIPESCN9A
SCHEMBL10195106 0.84 ALDH1A1 (0.42) SMN1; SMN2LMNATSHRALDH1A1HTT
SCHEMBL10195173 0.83 HTR2A (0.39) SMN1; SMN2LMNAALDH1A1HTTKDM4E
SCHEMBL10195451 0.82 SMN1; SMN2 (0.39) MAPK1SMN1; SMN2LMNATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 MAPK1 2927/4885SMN1; SMN2 2218/4885LMNA 4151/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 MAPK1 2263/4885SMN1; SMN2 2952/4885LMNA 4657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.